Table 3. Results of univariable and multivariable logistic regression models for being diagnosed with a sexual transmitted infection at mpox notification. Brazil, 2022.
| Demographic and clinical characteristic | OR(95%CI) | aOR(95%CI) |
|---|---|---|
| Sex at birth | ||
| Male | 3.38(2.30–4.95) | |
| Female | 1.00 | NS |
| NA | - | |
| Gender | ||
| Transgender women or tranvestites | 5.66(2.56–12.54) | 2.24(0.85–5.91) |
| Cisgender female | 1.00 | 1.0 |
| Cisgender male | 3.51(2.34–5.26) | 1.45(0.72–2.92) |
| Non-binary | 4.98(2.43–10.21) | 1.93(0.77–4.80) |
| Other | 4.06(2.38–6.92) | 1.86(0.86–4.03) |
| Missing/NA | 1.63(1.05–2.55) | 1.02(0.50–2.06) |
| Age | ||
| 15-24 | 1.72(1.14–2.61) | 1.85(1.21–2.84) |
| 25-34 | 2.36(1.60–3.47) | 2.02(1.36–3.00) |
| 35-49 | 2.00(1.35–2.95) | 1.70(1.14–2.53) |
| 50+ | 1.00 | 1.0 |
| Ethnicity/skin color | ||
| White/Asian | 1.00 | 1.0 |
| Black | 1.39(1.21–1.59) | 1.26(1.08–1.46) |
| Indigenous | 1.30(0.29–5.74) | 1.13(0.25–5.19) |
| Missing/NA | 0.79(0.66–0.96) | 0.92(0.76–1.13) |
| Region of residence | ||
| North | 2.15(1.58–2.92) | 1.55(1.13–2.12) |
| Northeast | 1.00 | 1.00 |
| Southwest | 1.10(0.89–1.37) | 1.37(1.08–1.73) |
| South | 1.46(1.12–1.91) | 1.48(1.11–1.95) |
| Central-West | 1.65(1.27–2.13) | 1.37(1.05–1.79) |
| Missing/NA | 2.99(1.08–8.27) | 4.54(1.5–13.78) |
| Sexual orientation | ||
| Heterosexual | 1,0 | NS |
| Homosexual | 2.25(1.69–2.99) | |
| Bisexual | 2.21(1.54–3.15) | |
| Pansexual | 2.38(1.22–4.68) | |
| Other | 0.97(0.61–1.54) | |
| Female at birth | 0.49(0.3–0.77) | |
| Missing/NA | 1.24(0.92–1.66) | |
| Men who have sex with men* | ||
| No | 1.00 | 1.00 |
| Yes | 2.20(1.70–2.85) | 1.57(1.20–2.05) |
| Female at birth | 0.52(0.33–0.82) | 0.84(0.42–1.70) |
| Missing/NA | 1.28(0.97–1.70) | 1.16(0.86–1.57) |
| Immunosuppressed | 1.0 | |
| No | 2.30(2.02–2.75) | NS |
| Yes | 0.34(0.26–0.44) | |
| Missing/NA | 1.0 | |
| Living with HIV | 1.0 | 1.0 |
| No | 2.22(1.94–2.55) | 1.72(1.36–2.18) |
| Yes | 0.36(0.28–0.45) | 0.64(0.48–0.85) |
| Missing/NA | 1.0 | 1.0 |
| Hospitalization | ||
| No | 1.0 | 1.0 |
| Yes | 1.58(1.23–2.02) | 1.51(1.16–1.95) |
| Missing/NA | 0.73(0.60–0.88) | 0.89(0.72–1.09) |
| Symptoms** | ||
| Bleeding | 2.09(1.33–3.28) | NS |
| Penile edema | 1.88(1.48–2.39) | 1.34(1.04–1.74) |
| Mucosa lesion | 1.71(1.28–2.28) | NS |
| Genital legion | 1.61(1.40–1.84) | NS |
| Oral lesion | 1.44(1.12–1.84) | NS |
| Generalized lymphadenopathy | 1.35(1.14–1.60) | NS |
| Sweating/shivering | 1.29(1.09–1.52) | NS |
| Anal lesion | 1.30(1.12–1.51) | NS |
| Rash | 1.44(1.27–1.64) | 1.22(1.04–1.42) |
| Sore throat | 1.23(1.04–1.46) | NS |
| Adenomegaly | 1.29(1.13–1.46) | NS |
| Fever | 1.26(1.11–1.43) | NS |
| Other symptoms | 1.33(1.16–1.52) | NS |
OR = Odds Ratio; aOR = Adjusted Odds Ratio; Md = Median; Q1 = 1st quartile; Q3 = 3rd quartile; STI = Sexually transmitted infection; NA = Not available; NS = Not-significant; *Individuals assigned as male at birth who reported sex only with other men or with men and women were considered MSM; **The reference category for the aOR and OR estimation for all symptoms were “did not present this symptom”.